BRIGHT MINDS BIOSCIENCES INC.

Profile

Company Names

BRIGHT MINDS BIOSCIENCES INC.

Addresses

19 VESTRY STREET, NEW YORK, NY 10013

1500 - 1055 WEST GEORGIA ST., VANCOUVER, A1 V6E 4N7

Phone Numbers

6474072515

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$35,918,025.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2024-11-04 
$34,599,955.00 
$34,599,955.00 
$0.00 
Equity 
12
2024-10-03 
$0.00 
$12,186.00 
$12,186.00 
 
11
2024-03-22 
$0.00 
$54,160.00 
$54,160.00 
Equity 
10
2022-09-06 
$0.00 
$149,784.00 
$149,784.00 
 
9
2022-08-30 
$0.00 
$220,329.00 
$220,329.00 
Equity 
8
2022-02-11 
$82,667.00 
$82,667.00 
$0.00 
Equity 
7
2022-02-04 
$59,765.00 
$59,765.00 
$0.00 
Equity 
6
2021-06-15 
$0.00 
$623,580.00 
$623,580.00 
 
5
2021-04-29 
$299,815.00 
$299,815.00 
$0.00 
Equity 
4
2021-03-17 
$516,175.00 
$838,699.00 
$322,524.00 
Equity 
3
2020-11-02 
$1,602.00 
$1,602.00 
$0.00 
Equity 
2
2020-09-18 
$218,040.00 
$218,040.00 
$0.00 
Equity 
1
2020-07-23 
$140,006.00 
$280,012.00 
$140,006.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NILS 
 
BOTTLER 
DIRECTOR
NILS 
CHRISTIAN 
BOTTLER 
DIRECTOR
NILS 
BOTTLER 
DIRECTOR
JEREMY 
 
FRYZUK 
DIRECTOR
ALAN 
 
KOZIKOWSKI 
EXECUTIVE OFFICER, DIRECTOR
JAN 
 
PEDERSEN 
DIRECTOR, EXECUTIVE OFFICER
JAN 
TORLEIF 
PEDERSEN 
EXECUTIVE OFFICER, DIRECTOR
JAN TORLEIF 
 
PEDERSEN 
EXECUTIVE OFFICER, DIRECTOR
GIDEON 
 
SHAPIRO 
EXECUTIVE OFFICER
REVATI 
 
SHEENIWAS 
EXECUTIVE OFFICER
REVATI 
 
SHREENIWAS 
EXECUTIVE OFFICER
MARK 
 
SMITH 
EXECUTIVE OFFICER
GEVO, INC.   |  SIGMA PHARMACEUTICALS LTD   |  EQUICAP, INC.   |  PUBLIC MEDIA WORKS INC   |  AHS PHARMSTAT, L.L.C.   |  UCAN SABAL INVESTMENT LLC   |  OIL PURIFICATIONS SYSTEMS INC   |  KNOX 1000 PARTNERS, LTD.   |  UCAN SERRUS WALK, LLC   |  UCAN CEREVELLUM INVESTMENT, LLC   |  UCAN VERDEECO INVESTMENT, LLC   |  BINGE, LLC   |  DELIVERY AGENT INC   |  GEOSPATIAL CORP   |  DIAMCOR MINING INC.   |  SYMBIONT.IO, INC.   |  NEXTBIOME, INC.   |  LARGO RESOURCES LTD.   |  NIOCORP DEVELOPMENTS LTD   |  ELEOS TECHNOLOGIES LLC   |  DALCOR PHARMACEUTICALS US, LLC   |  DALCOR PHARMACEUTICALS CANADA INC.   |  IBC ADVANCED ALLOYS CORP.   |  24 HOUR HOLDINGS I CORP.   |  FINCH THERAPEUTICS, INC.   |  HSM HWY 66 STORAGE LP   |  CARDINAL ANALYTX, INC.   |  FINCH THERAPEUTICS GROUP, INC.   |  TRION ENERGY SOLUTIONS CORP.   |  BAYOTECH, INC.   |  TRUCK IT APP, LLC   |  CSAC ACQUISITION INC.   |  ROCHESTER 153, LLC   |  BION ENVIRONMENTAL TECHNOLOGIES INC   |  ICANIC BRANDS CO INC.   |  CABRAL GOLD INC.   |  PAN ARCTIC CAPITAL LLC   |  SION POWER CORP   |  ZEAMO INC   |  VISUM PHARMA, INC.   |  HORIZON OCH PARTNERS, LLC   |  TRION BATTERY TECHNOLOGIES INC.   |  DAVIS INVESTMENT VENTURES FUND V-B, L.P.   |  DAVIS INVESTMENT VENTURES FUND V, L.P.   |  DAVIS INVESTMENT VENTURES FUND V-A, L.P.   |  PREALIZE HEALTH, INC.   |  DIV REIT IV, LLC   |  BRIGHT MINDS BIOSCIENCES INC.   |  DIV GALEN INVESTOR, L.P.   |  DIV REIT V, LLC   |  GALEN STREET REIT, LLC   |  FLOREY BIOSCIENCES, INC.   |  CARBON COUNTRY LLC   |  JUTE INC.   |  NEXBEN INC.
DAVID 
WEINER 
DIRECTOR
DOUGLAS 
 
WILLIAMSON 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-11-04 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-10-03 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-22 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-09-06 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-08-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-02-11 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-02-04 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-06-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#